Athena Athena

X

Find Radio Compass News for Empagliflozin

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - 10MG
  • TABLET;ORAL - 25MG
  • TABLET;ORAL - 10MG;5MG
  • TABLET;ORAL - 25MG;5MG

https://www.globenewswire.com/news-release/2024/03/18/2848135/0/en/Inventiva-announces-positive-results-from-the-Phase-II-LEGEND-Proof-of-Concept-study-combining-lanifibranor-with-empagliflozin-in-patients-with-MASH-NASH-and-T2D.html

GLOBENEWSWIRE
18 Mar 2024

https://www.globenewswire.com//news-release/2024/03/13/2845818/0/en/Inventiva-to-present-the-results-of-LEGEND-Phase-IIa-combination-trial-with-lanifibranor-and-empagliflozin-in-patients-with-MASH-NASH-and-T2D.html

GLOBENEWSWIRE
13 Mar 2024

https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/boehringers-jardiance-now-gets-cdsco-nod-for-chronic-kidney-disease/articleshow/107699891.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMIC TIMES
14 Feb 2024

https://www.boehringer-ingelheim.com/promising-phase-ii-results-chronic-kidney-disease

PRESS RELEASE
04 Nov 2023

https://www.businesswire.com/news/home/20231103813579/en

BUSINESSWIRE
03 Nov 2023

https://endpts.com/boehringer-agrees-to-comply-with-cms-price-negotiations-over-blockbuster-jardiance/

Zachary Brennan ENDPTS
27 Sep 2023

https://www.prnewswire.com/news-releases/us-fda-approves-jardiance-for-the-treatment-of-adults-with-chronic-kidney-disease-301936176.html

PR NEWSWIRE
23 Sep 2023

https://www.reuters.com/business/healthcare-pharmaceuticals/us-name-first-10-drugs-medicare-price-negotiation-2023-08-29/

REUTERS
30 Aug 2023

https://pharmaphorum.com/news/jardiance-cleared-eu-ckd-challenging-forxiga

PHARMAPHORUM
26 Jul 2023

https://www.businesswire.com/news/home/20230623740785/en/Jardiance%C2%AE-recommended-for-the-treatment-of-adults-with-chronic-kidney-disease-in-the-EU

BUSINESSWIRE
24 Jun 2023

https://www.pharmaceutical-technology.com/news/fda-grants-access-to-new-class-of-paediatric-diabetes-medicine/

Akosua Mireku PHARMACEUTICAL TECHNOLOGY
21 Jun 2023

https://www.prnewswire.com/news-releases/fda-approves-new-class-of-medicines-to-treat-pediatric-type-2-diabetes-301855985.html

PR NEWSWIRE
20 Jun 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212339

FDA
12 Jun 2023

https://www.reuters.com/business/healthcare-pharmaceuticals/boehringers-profit-up-14-jardiance-gains-offset-impairments-2023-03-29/

REUTERS
30 Mar 2023

https://www.fiercepharma.com/pharma/boehringer-ingelheim-and-eli-lillys-jardiance-get-big-lift-heart-failure-indications

Kevin Dunleavy FIERCE PHARMA
29 Mar 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-29-2023-93363.pdf

FDA
29 Mar 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212343

FDA
10 Mar 2023

https://www.pharmatimes.com/news/nice_fails_to_recommend_boehringer_ingelheim_and_lilly_alliances_empagliflozin_1486404

PHARMATIMES
08 Feb 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212362

FDA
30 Jan 2023

https://www.pharmaceutical-technology.com/news/fda-lilly-boehringer-ingelheim-jardiance/

PHARMACEUTICAL TECHNOLOGY
23 Jan 2023

https://www.prnewswire.com/news-releases/us-fda-accepts-supplemental-new-drug-application-for-jardiance-for-adults-with-chronic-kidney-disease-301726873.html

PR NEWSWIRE
20 Jan 2023

https://www.indianpharmapost.com/news/torrent-enters-into-co-marketing-partnership-with-boehringer-ingelheim-india-13452

INDIANPHARMAPOST
15 Dec 2022

https://www.fiercepharma.com/pharma/eli-lilly-committed-gip-class-expects-over-30-billion-2023-revenues-4-new-product-launches

Zoey Becker FIERCEPHARMA
14 Dec 2022

https://www.businesswire.com/news/home/20221207005405/en

BUSINESSWIRE
07 Dec 2022

https://www.europeanpharmaceuticalreview.com/news/177204/jardiance-improves-blood-sugar-control-in-type-2-diabetes/

EUROPEANPHARMACEUTICALREVIEW
07 Dec 2022

https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-boehringer-say-jardiance-slows-kidney-disease-progression-trial-2022-11-04/

REUTERS
05 Nov 2022

https://www.businesswire.com/news/home/20221104005412/en

BUSINESSWIRE
04 Nov 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212382

FDA
28 Sep 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212366

FDA
09 Aug 2022

https://endpts.com/sales-of-boehringer-ingelheims-diabetes-pulmonary-drugs-jump-amid-11b-in-first-half-total/

Beth Snyder Bulik ENDPTS
04 Aug 2022

https://www.expresspharma.in/zydus-gets-final-us-fda-approval-for-empagliflozin-tablets/

EXPRESS PHARMA
04 Aug 2022

https://health.economictimes.indiatimes.com/news/pharma/zydus-receives-final-approval-from-usfda-for-type-2-diabetes-tablets/93344737

ECONOMIC TIMES
03 Aug 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212138

FDA
03 Aug 2022

https://health.economictimes.indiatimes.com/news/pharma/zydus-receives-final-fda-approval-for-type-2-diabetes-drug/92797033

ET HEALTH
11 Jul 2022

https://www.globenewswire.com/news-release/2022/07/07/2476242/0/en/Inventiva-announces-the-screening-of-the-first-patient-in-LEGEND-a-Phase-IIa-combination-trial-with-lanifibranor-and-empagliflozin-in-patients-with-NASH-and-T2D.html

GLOBENEWSWIRE
07 Jul 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212198

FDA
07 Jul 2022

https://www.fiercepharma.com/marketing/lilly-and-boehringers-jardiance-poised-battle-azs-farxiga-chronic-kidney-disease-spherix

Natalie Missakian FIERCEPHARMA
24 Jun 2022

https://www.prnewswire.com/news-releases/jardiance-decreased-relative-risk-of-hospitalization-for-heart-failure-by-50-versus-dpp-4-inhibitors-and-by-30-versus-glp-1-receptor-agonists-in-adults-with-type-2-diabetes-in-real-world-evidence-study-301561303.html

PRNEWSWIRE
05 Jun 2022

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/boehringer-ingelheim-gets-cdsco-nod-for-jardiance-to-treat-for-new-heart-failure-indication/articleshow/91671152.cms

Viswanath Pilla ECONOMIC TIMES
19 May 2022

https://endpts.com/eli-lilly-and-boehringer-ingelheim-urge-women-to-become-their-own-heart-health-advocates-in-new-campaign/

ENDPTS
21 Apr 2022

https://www.fiercepharma.com/asia/jardiance-sparks-boehringer-ingelheims-2021-sales-potential-much-more-growth-2022

K. Dunleavy FIERCEPHARMA
06 Apr 2022

https://www.reuters.com/business/healthcare-pharmaceuticals/boehringers-operating-income-edges-up-jardiance-animal-health-2022-04-05/

Ludwig Burger REUTERS
05 Apr 2022

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/himachal-pradesh-high-court-stays-drl-from-selling-bis-diabetic-drug-jardiance/articleshow/90575276.cms

Viswanath Pilla ECONOMIC TIMES
01 Apr 2022

https://www.prnewswire.com/news-releases/jardiance-phase-iii-empa-kidney-trial-will-stop-early-due-to-clear-positive-efficacy-in-people-with-chronic-kidney-disease-301504008.html

PRNEWSWIRE
16 Mar 2022

https://www.fiercepharma.com/pharma/eli-lilly-boehringer-ingelheims-jardiance-widens-heart-failure-foothold-eu-approval-turning

F. Kansteiner FIERCEPHARMA
08 Mar 2022

https://www.europeanpharmaceuticalreview.com/news/169008/empagliflozin-benefit-adults-hospitalised-acute-heart-failure/

EUROPEANPHARMACEUTICALREVIEW
04 Mar 2022

https://www.prnewswire.com/news-releases/jardiance-provided-a-significant-clinical-benefit-in-adults-stabilized-in-hospital-following-acute-heart-failure-in-empulse-phase-iii-trial-301492927.html

PRNEWSWIRE
01 Mar 2022

https://seekingalpha.com/news/3805360-lilly-boehringer-ingelheims-jardiance-granted-expanded-indication-in-heart-failure

J. Block SEEKINGALPHA
25 Feb 2022

http://www.pharmafile.com/news/605921/nice-approves-new-treatment-chronic-heart-failure

PHARMAFILE
07 Feb 2022
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY